18 June 2013
Keywords: RegeneRx, Potential strategic options, R&D pipeline
Article | 02 February 2012
US biotech firm RegeneRx Biopharmaceuticals. (OTC Bulletin Board: RGRX) revealed yesterday that it has hired investment bankers, Ameritech Advisors and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 February 2012
1 February 2012
© 2013 thepharmaletter.com